Entrotech life sciences
2012
FOUNDED
PRIVATE
STATUS
21-30
EMPLOYEES
Series B
LATEST DEAL TYPE
$2.5M
LATEST DEAL AMOUNT
Description
Developer of antimicrobial healthcare devices. The company specializes in developing and designing a chlorhexidine that can be utilized In any self-adhesive device or liquid delivery application.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Primary Office
- 409 Illinois Street
- San Francisco, CA 94158
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Entrotech life sciences’s full profile, request a free trial.
Entrotech life sciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series B) | 08-Dec-2015 | $2.5M | 00.00 | 000.00 | Completed | Startup |
Entrotech life sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 0,000,000 | 00.000000 | 00.0 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |